Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Journey Medical Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 1.64M | 1.76M | +115.1K (+7.0%) |
| Value | $7.94M | $6.52M | −$1.42M (−17.8%) |
New holders (4)
Institutions that held Journey Medical Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Creative Planning | 11,764 | $44.0K | 0.00% |
| Vanguard Group Inc | 10,435 | $39.0K | 0.00% |
| Essex Investment Management Co LLC | 1,400 | $5.00K | 0.00% |
| B. Riley Wealth Management, Inc. | 15,000 | – | – |
Sold out (5)
Institutions that held Journey Medical Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Millrace Asset Group, Inc. | 81,070 | $392.0K |
| Millennium Management LLC | 21,449 | $103.0K |
| Renaissance Technologies LLC | 15,600 | $75.0K |
| Goldman Sachs Group Inc | 10,926 | $53.0K |
| Plante Moran Financial Advisors, LLC | 200 | $1.00K |